166 related articles for article (PubMed ID: 25851994)
21. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
22. MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3.
Bai X; Han G; Liu Y; Jiang H; He Q
Biomed Pharmacother; 2018 Jul; 103():1482-1489. PubMed ID: 29864933
[TBL] [Abstract][Full Text] [Related]
23. miR-136 suppresses tumor invasion and metastasis by targeting RASAL2 in triple-negative breast cancer.
Yan M; Li X; Tong D; Han C; Zhao R; He Y; Jin X
Oncol Rep; 2016 Jul; 36(1):65-71. PubMed ID: 27108696
[TBL] [Abstract][Full Text] [Related]
24. miR-135b promotes proliferation and metastasis by targeting APC in triple-negative breast cancer.
Lv ZD; Xin HN; Yang ZC; Wang WJ; Dong JJ; Jin LY; Li FN
J Cell Physiol; 2019 Jul; 234(7):10819-10826. PubMed ID: 30624764
[TBL] [Abstract][Full Text] [Related]
25. miR-613 inhibits cell migration and invasion by downregulating Daam1 in triple-negative breast cancer.
Xiong H; Yan T; Zhang W; Shi F; Jiang X; Wang X; Li S; Chen Y; Chen C; Zhu Y
Cell Signal; 2018 Apr; 44():33-42. PubMed ID: 29339084
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating BRCA1 expression.
Matamala N; Vargas MT; González-Cámpora R; Arias JI; Menéndez P; Andrés-León E; Yanowsky K; Llaneza-Folgueras A; Miñambres R; Martínez-Delgado B; Benítez J
Oncotarget; 2016 Apr; 7(15):20068-79. PubMed ID: 26933805
[TBL] [Abstract][Full Text] [Related]
27. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes.
Liu Y; Cai Q; Bao PP; Su Y; Cai H; Wu J; Ye F; Guo X; Zheng W; Zheng Y; Shu XO
Breast Cancer Res Treat; 2015 Jul; 152(1):183-191. PubMed ID: 26062749
[TBL] [Abstract][Full Text] [Related]
28. Loss of RAB1B promotes triple-negative breast cancer metastasis by activating TGF-β/SMAD signaling.
Jiang HL; Sun HF; Gao SP; Li LD; Hu X; Wu J; Jin W
Oncotarget; 2015 Jun; 6(18):16352-65. PubMed ID: 25970785
[TBL] [Abstract][Full Text] [Related]
29. Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers.
Fkih M'hamed I; Privat M; Ponelle F; Penault-Llorca F; Kenani A; Bignon YJ
Cell Oncol (Dordr); 2015 Dec; 38(6):433-42. PubMed ID: 26392359
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-224 Promotes Tumorigenesis through Downregulation of Caspase-9 in Triple-Negative Breast Cancer.
Zhang L; Zhang X; Wang X; He M; Qiao S
Dis Markers; 2019; 2019():7378967. PubMed ID: 30886656
[TBL] [Abstract][Full Text] [Related]
31. Targeting of miR9/NOTCH1 interaction reduces metastatic behavior in triple-negative breast cancer.
Mohammadi-Yeganeh S; Mansouri A; Paryan M
Chem Biol Drug Des; 2015 Nov; 86(5):1185-91. PubMed ID: 25963903
[TBL] [Abstract][Full Text] [Related]
32. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF
Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA TUG1 sponges miR-197 to enhance cisplatin sensitivity in triple negative breast cancer.
Tang T; Cheng Y; She Q; Jiang Y; Chen Y; Yang W; Li Y
Biomed Pharmacother; 2018 Nov; 107():338-346. PubMed ID: 30098551
[TBL] [Abstract][Full Text] [Related]
34. miR-103 regulates triple negative breast cancer cells migration and invasion through targeting olfactomedin 4.
Xiong B; Lei X; Zhang L; Fu J
Biomed Pharmacother; 2017 May; 89():1401-1408. PubMed ID: 28320108
[TBL] [Abstract][Full Text] [Related]
35. SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status.
Adam MG; Matt S; Christian S; Hess-Stumpp H; Haegebarth A; Hofmann TG; Algire C
Cell Cycle; 2015; 14(23):3734-47. PubMed ID: 26654769
[TBL] [Abstract][Full Text] [Related]
36. Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells.
Al-Othman N; Hammad H; Ahram M
Gene; 2018 Oct; 675():128-135. PubMed ID: 29964098
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-145 functions as a tumor suppressor by targeting matrix metalloproteinase 11 and Rab GTPase family 27a in triple-negative breast cancer.
Tang L; Wei D; Yan F
Cancer Gene Ther; 2016 Aug; 23(8):258-65. PubMed ID: 27364572
[TBL] [Abstract][Full Text] [Related]
38. CircAHNAK1 inhibits proliferation and metastasis of triple-negative breast cancer by modulating miR-421 and RASA1.
Xiao W; Zheng S; Zou Y; Yang A; Xie X; Tang H; Xie X
Aging (Albany NY); 2019 Dec; 11(24):12043-12056. PubMed ID: 31857500
[TBL] [Abstract][Full Text] [Related]
39. EZH2 induces the expression of miR-1301 as a negative feedback control mechanism in triple negative breast cancer.
Wu Q; Chen Z; Zhang G; Zhou W; Peng Y; Liu R; Chen C; Feng J
Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):693-700. PubMed ID: 29790898
[TBL] [Abstract][Full Text] [Related]
40. miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer.
D'Ippolito E; Plantamura I; Bongiovanni L; Casalini P; Baroni S; Piovan C; Orlandi R; Gualeni AV; Gloghini A; Rossini A; Cresta S; Tessari A; De Braud F; Di Leva G; Tripodo C; Iorio MV
Cancer Res; 2016 Sep; 76(18):5562-72. PubMed ID: 27402080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
